Dana dhuwit diétung saben saham an2therapeutics.com (ANTX)

AN2 Bio - logo grafis emiten ANTX

The use of external CDMO facilities minimizes the risk of production downtime in California for AN2 Therapeutics, Inc. (ANTX). Cash per share clearly illustrates current liquidity, with the latest value recorded as 1.71. AN2 Therapeutics, Inc. (ANTX) develops antibiotics against resistant bacteria to ensure stable sales. Patent protection and FDA orphan drug status create significant barriers to entry for new market players.

AN2 Therapeutics (ANTX): Dana dhuwit saben saham saka 28.04.2023 nganti 21.11.2026

ANTX (an2therapeutics.com): rincian analitis lan laporan miturut indikator

- rega saiki lan proyeksi nilai saham:
Analisis dhasar perusahaan:ANTX, AN2 Bio
Produk mawa merek AN2 Therapeutics, Inc.

Cash per share reflects the volume of an organization's liquid assets allocated to a single security. This cash per share valuation is based on a daily recalculation of cash reserves, eliminating reporting time lags. Growth in this metric confirms financial stability and reduces default risk. For AN2 Therapeutics, Inc. (ANTX), this is critical, as labor-intensive clinical trials require a constant influx of capital. The presence of reserves ensures payment for physicians' work during the automated synthesis of drugs.